Deproteinization with ZnSO4–Ba(OH)2 reduces the photodegradation of montelukast during plasma sample preparation for HPLC analysis

A turn off-on fluorometric and paper based colorimetric dual-mode sensor for isoniazid detection

In the present study, Cobalt oxyhydroxide (CoOOH) nanosheets were applied for establishing a dual fluorometric and smartphone-paper-based colorimetric method to detect isoniazid. CoOOH nanosheets quenched the fluorescence emission of sulfur and nitrogen co-doped carbon dots (S,N-CDs) due to inner filter effect (IFE). The quenched fluorescence intensity of S,N-CDs restored in the presence of isoniazid due to destroying CoOOH nanosheets by this drug. Moreover, with adding isoniazid the solution color of CoOOH nanosheets altered from brownish yellow to pale yellow. We exploited these facts to design a turn off-on fluorometric and paper based colorimetric sensor for isoniazid measurement at the range of 0.5-10 and 5-100 μM with detection limits of 0.28 μM and 4.0 μM, respectively. The introduced dual sensor was used for pharmaceutical, environmental and biological analysis of isoniazid with satisfactory results. The paper based colorimetric sensor can be applied for isoniazid portable monitoring by smartphone as a detector and even nocked eyes.

Development of LC-MS/MS method and application to bioequivalence study of a light sensitive drug montelukast

OBJECTIVE

The aim of the study was to develop a simple, highthroughput and sensitive LC-MS/MS method and apply to a bioequivalence study of montelukast, a light sensitive drug.

METHOD

The effects of organic modifiers in mobile phase, protein precipitation agent to plasma sample ratio, and light on montelukast stability in unprocessed and processed human plasma, were evaluated. Validation was conducted in accordance with European Medicines Agency Guideline on bioanalytical method validation.

RESULTS

No interference peak was observed when acetonitrile was used as an organic modifier. Acetonitrile to plasma ratio of 4:1 produced clean plasma sample. Approximately 3 % of cis isomer was detected in unprocessed plasma samples while 21 % of cis isomer was detected in processed plasma samples after exposing to fluorescent light for 24h. The standard calibration curve was linear over 3.00-1200.00 ng/mL. All method validation parameters were within the acceptance criteria.

CONCLUSION

The validated method was successfully applied to a bioequivalence study of two montelukast formulations involving 24 healthy Malaysian volunteers. The light stability of a light sensitive drug in unprocessed and processed human plasma samples should be studied prior to pharmacokinetic/bioequivalence studies. Measures could then be taken to protect the analyte in human plasma from light degradation.